About: p53:264-272 Peptide     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : owl:DeprecatedClass, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • p53:264-272 Peptide
rdfs:subClassOf
Semantic_Type
  • Amino Acid, Peptide, or Protein
  • Pharmacologic Substance
Preferred_Name
  • p53:264-272 Peptide
NSC_Code
  • 717111
OLD_PARENT
  • Peptide_Vaccine
OLD_ROLE
  • Chemical_Or_Drug_Affects_Cell_Type_Or_Tissue some 'Cytotoxic T-Lymphocyte'
  • Chemical_Or_Drug_Has_Mechanism_Of_Action some 'Antigen Sensitization'
  • Chemical_Or_Drug_Has_Physiologic_Effect some 'T-Cell Activation'
  • Chemical_Or_Drug_Has_Physiologic_Effect some Immunopotentiation
UMLS_CUI
  • C1518773
Concept_Status
  • Retired_Concept
OLD_ASSOCIATION
  • 'Cellular Tumor Antigen p53'
Legacy_Concept_Name
  • P53_264-272_Peptide_MPS-128
FULL_SYN
  • PR-147SYNCI
  • MPS-128SYNCI
  • p53:264-272 PeptidePTNCI
DEFINITION
  • A synthetic peptide derived from the tumor suppressor protein p53 with potential use in cancer immunotherapy. p53:264-272 peptide consists of amino acid residues 264 through 272 of the p53 protein. Vaccination with this agent may induce a cytotoxic host immune response to tumor cells. (NCI04)NCI
DesignNote
  • Thu May 24 14:54:19 EDT 2012 - See 'p53_Peptide_Vaccine'
code
  • C2784
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 46 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software